Feasibility study of a systematic approach for deprescribing of statins and proton pump inhibitors in nursing home residents

Completed

• Conditions: Polyfarmacie; polypharmacy; the concurrent use of multiple medications by a patient; 10017947; 10001474

• Registration Number: NL-OMON46524
• Lead Sponsor: Zuyderland Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 125

Inclusion Criteria

Participant uses a statin
Or/and participant uses a proton pump inhibitor
Participant signs informed consent

Exclusion Criteria

Participant is there for short term nursing home admission (<3 months)
Participant is there for hospice admission.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>1. Decrease in PPI and statin use for the short and long term.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>1. All possible negative effects of deprescribing<br /><br>2. The feasibility and acceptance of this deprescribing proces for patients,<br /><br>family and doctors.</p><br>